Organizational Structure & Governance Model
Evidencing our commitment to the principles of automomy, accountability, transparency and operating at the very highest ethical standards and financial level of efficiency, we adopted an organizational structure and governance model that is appropriate to, and consistent with, how a truly independent research organization should be structured and operated.
Leveraging Social Entrepreneurialism:
The Importance of Seeking Certified B-Corporation Status
Certified B-Corporations, derived from the concept of “social entrepreneurialism”, are the offshoot of a new type of global business movement to leverage business as a force for good by balancing purpose and profit. B-Corps adopt a mission to create and sustain social value, not just private value; question the status quo to create new approaches and alternative solutions to a major social problem; draw upon the best business and non-profit thinking to develop strategies that maximize social impact; and look for a long-term social ROI and lasting impact, not just a quick hit.
Legally required to consider their impact on workers, customers, suppliers, community and environment, B-Corps harness the power of business and use profits and growth as a means to a greater end, the goal being reduced inequality, less poverty, a healthier environment, stronger communities, high quality jobs, etc.. They seek the highest standard of verified social and environmental performance, public transparency and legal accountability...and build trust and establish value by virtue of verification from third-party non-profit B-Lab. Worldwide, there are about 3,200 B-Corporations.
To learn more about "Social Entrepreneurship" see Duke University Graduate School of Business Professor Gregory Dees's seminal piece on the concept he created entitled "The Meaning of Social Entrepreneuurship" by clicking here.
Meet the Team
To accomplish our lofty mission, we have attracted a stellar team of highly experienced, seasoned executives and experts, each having decades of industry-specific leadership experience. Indeed, we have many highly-qualified individuals looking to join the team...most of whom are attracted to our focus on doing social good as an aspiring Certified B-Corporation...rather than maximizing our bottom line. We believe that this says a lot about the quality of the people this initiative continues to attract.
A seasoned industry veteran having four decades of management-level experience in the self-funded, managed care and outsourcing sectors, Richard Nicholas has been known to regularly beat royal flushes with two jacks. He has owned and held executive positions with national TPAs, BPOs and MCOs; represented more than 200 TPAs before the U.S. Congress and been trusted (along with his long-time partner, Nick Cole) to facilitate more TPA mergers and acquisitions than anyone. An innovator, author and newly-minted “social entrepreneur”, Richard conceived of and created the Research Consortium to undertake much needed payor-focused translational research on new and emerging medical technologies and health innovations and to facilitate more, smarter and less costly medical research. Richard earned a BA with distinction from Boston College and an MBA from Duke University’s Fuqua Graduate School of Business.
Barbara Krasner has two decades of experience helping organizations across the U. S., in Europe and Africa create and successfully fund programs in healthcare, pharmacogenomics, software development, education, etc. A former academic professor, Barbara has served as a consultant to, and officer of, private and public organizations for which she has raised $20+ million. She is skilled at creating high-level collaborations between non-profit organizations, government entities, for-profit companies and funding institutions and has worked successfully in this regard with the Cleveland Clinic Foundation, the Robert Wood Johnson Foundation, the Army National Guard and the American National Red Cross (where she restructured and managed its long term grants program). Barbara holds an undergraduate degree from Johns Hopkins University and a MA and Ph.D. from the University of North Carolina.
Anupam Das is seasoned software developer with 16 years’ experience in the healthcare domain, and a special focus in HIPPA compliance, data security and interoperability. Vast experience with all popular EMR systems (e.g., Epic, Meditech, Mckesson, GE, EClinicalworks, Nextgen, Cerner, QuadraMed) and with registry integrations, data lakes; complex lab integrations; ePrescription systems; custom indexing and processing of Big Data generated from EMR systems; developing custom interfaces for health plan administration platforms for payors (e.g., Aetna, BCBS, CIGNA, Humana, UHC) and popular industry vendors (e.g., Availity, Emdeon/CHANGE Healthcare), InstaMed, RelayHealth, SureScript, Zirmed). Arupam participated in Certification Commission for Healthcare Information Technology and served as a NCQA consultant on EHR implementation. Importantly, Anupam is an expert in FHIR (Fast Healthcare Inter-operability Resources) Specification, the standard for exchanging healthcare information electronically; to facilitate interoperation between legacy health care systems, to provide health care info to providers and patients on all devices (e.g. tablets, cell phones), and to enable third-party app development and interoperability. Anupam has a Bachelor of Engineering in Computer Engineering from Mumbai University.
Paul Kyrychenko, Ph. D
Paul Kyrychenko, Ph. D is an expert in applied healthcare, health economics outcomes research (HEOR) and pharmaceutical, clinical outcome and epidemiological research having more than 20 years of hands-on experience in research designs/instruments, risk stratification tools, modeling and statistical analysis utilizing big and complex healthcare data from diverse sources (e.g., medical and pharmacy claims, EMR, disease registries). During his career Paul has served as an executive scientific advisor to a $150 billion integrated pharmacy provider where he led collaborations with pharmaceutical manufacturers to ensure consistency of drug utilization, adherence and compliance and provide ROI, cost-effectiveness and clinical outcomes insights re: product specific programs. He has developed and validated microsimulation and economic models that demonstrate the impact of changes in medication adherence on medical service spending; replicate the impact of pharmacogenomic testing on provider prescribing patterns; and simulate the impact of integration of EMR data on acceleration of the prior authorization and healthcare risk even identification process. Paul has considerable experience working with health plans, large employers and government payors. An author and contributor to many peer-reviewed journals, Paul is the holder of several degrees (including three doctoral degrees) from the Weill Medical College of Cornell University; the SAS Institute; the University of Alabama at Birmingham, School of Public Health; and the Institute of Epidemiology and Infectious Diseases, Ukraine Academy of Medical Science.
Board of Distinguished Advisors
Made up of largely retired industry experts, the six members of the Research Consortium’s Board of Distinguished Advisors have an aggregate 200 years of industry-specific experience. Our Distinguished Advisors have owned and/or operated six commercial/union TPAs; served on numerous industry professional society boards; won an Emmy for communications; headed research for three global drug companies; and guided the development of a successful (AI, blockchain) tech firm.